Evidence map›Paper›PMID 10597233›Full record

ArticleOncogene1999

Regulation by Gi2 proteins of v-fms-induced proliferation and transformation via Src-kinase and STAT3.

I Corre, H Baumann, S Hermouet

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 39 citations in OpenAlex.

  1. Active GαMolecular and cellular biology · 2023
    Article
  2. Article
  3. Article
  4. Review
  5. Regulation of neurite outgrowth by G(i/o) signaling pathways.Frontiers in bioscience : a journal and virtual library · 2008
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

I CorreGroupe Cytokines, Récepteurs et Transduction de Signal, INSERM U463, Institut de Biologie, Nantes, France.
H Baumann
S Hermouet
Inserm · FRRoswell Park Comprehensive Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously showed that Gi2 proteins interfere with the transduction of CSF-1 receptor (CSF-1R) proliferation signals (Corre and Hermouet, 1995). To identify CSF-1R pathways controlled by Gi2, we transfected v-fms, the oncogenic equivalent of CSF-1R, in NIH3T3 cells in which Gi2 proteins were inactivated by stably expressing a dominant negative mutant form of the alpha subunit of Gi2 (alpha i2-G204A). Expression of alpha i2-G204A resulted in decreased Src-kinase activity, delayed activation of p42 ERK-MAPK, decreased cyclin D1 expression and reduced proliferation in response to serum. In alpha i2-G204A cells transfected with v-fms, Src-kinase activity remained deficient but p42 MAPK activity and cyclin D1 expression were similar to those of vector/v-fms cells, suggesting that v-fms bypasses Src to activate the ERK-MAPK cascade. However, DNA synthesis and focus formation were inhibited by up to 80% in alpha i2-G204A/v-fms cells compared to vector/v-fms cells. We found that tyrosine phosphorylation of STAT3, also activated by CSF-1R/v-fms, was inhibited in alpha i2-G204A/v-fms cells; in addition, expression of an 85 kDa, C-terminal truncated form of STAT3 (STAT3 delta) was constitutively increased. Both the inhibition of v-fms-induced STAT3 tyrosine phosphorylation and the increased expression of STAT3 delta were reproduced by transfecting a dominant negative mutant of Src. Last, we show that expression of STAT3 delta 55C, a mutant form of STAT3 lacking the last 55 C-terminal amino acids, is sufficient to inhibit DNA synthesis and v-fms-induced transformation in NIH3T3 cells. In summary, adequate regulation by Gi2 proteins of the activity of both Src-kinase and STAT3 is required for optimal cell proliferation in response to CSF-1R/v-fms.

Indexed as

Adaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular Transport3T3 CellsAmino Acid SequenceAnimalsCell DivisionCell Transformation, ViralCyclin D1DNA-Binding ProteinsDNA ReplicationGTP-Binding Protein alpha Subunits, Gi-GoMAP Kinase Signaling SystemMiceMolecular Sequence DataOncogene Protein gp140(v-fms)PhosphorylationAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportCyclin D1DNA-Binding ProteinsFyn protein, mouseGTP-Binding Protein alpha Subunits, Gi-GoOncogene Protein gp140(v-fms)ProteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-fynProto-Oncogene Proteins pp60(c-src)Recombinant Fusion ProteinsShc1 protein, mouseShc Signaling Adaptor ProteinsSrc Homology 2 Domain-Containing, Transforming Protein 1Stat3 protein, mouseSTAT3 Transcription FactorTrans-Activators

Identifiers

PMID10597233
OpenAlexW2324860089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.